Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2022 · 10-Q
Revenue$274.47M$274.47M+14.9% vs Q3 2021 Net Income$50.22M$50.22M+22.9% vs Q3 2021 EPS Diluted$0.99$0.99+22.2% vs Q3 2021 Gross Profit$155,060,000+11.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$66,297,000+34.7% Free Cash Flowderived$64,068,000+47.3% Margins · derivedGross margin56.5%−1.7 pt vs Q3 2021
Operating margin30.1%−0.7 pt vs Q3 2021
Net margin18.3%+1.2 pt vs Q3 2021
ended Dec 31, 2021 · filed Feb 3, 2022 · 34 d after period end